EGETIS THERAPEUTICS Trademark

Trademark Overview


On Tuesday, March 23, 2021, a trademark application was filed for EGETIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EGETIS THERAPEUTICS trademark a serial number of 79312278. The federal status of this trademark filing is IR CANCELLED - NO TRANSFORMATION FILED as of Friday, May 20, 2022. This trademark is owned by Egetis Therapeutics AB. The EGETIS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medical and veterinary preparations and substances, namely, for the treatment of acetaminophen/paracetamol over dose, MCT8 deficiency, RTHb, oncological, neurological, endocrinological, metabolic, hematological, eye, autoimmune and inflammatory related diseases; vaccines; sanitary preparations for medical use; dietetic and nutritional preparations for medical use; diagnostic preparations for medical use; chemical reagents for medical use; diagnostic tests for medical use

Medical research; biological and chemical research; research and development of new medicines and medical preparations; medical and chemical laboratories; scientific and industrial research relating to medicinal or veterinary practice; diagnostic and screening services relating to medicinal or veterinary research and development; informational services relating to medicinal or veterinary research and development
egetis therapeutics

General Information


Serial Number79312278
Word MarkEGETIS THERAPEUTICS
Filing DateTuesday, March 23, 2021
Status401 - IR CANCELLED - NO TRANSFORMATION FILED
Status DateFriday, May 20, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical and veterinary preparations and substances, namely, for the treatment of acetaminophen/paracetamol over dose, MCT8 deficiency, RTHb, oncological, neurological, endocrinological, metabolic, hematological, eye, autoimmune and inflammatory related diseases; vaccines; sanitary preparations for medical use; dietetic and nutritional preparations for medical use; diagnostic preparations for medical use; chemical reagents for medical use; diagnostic tests for medical use
Goods and ServicesMedical research; biological and chemical research; research and development of new medicines and medical preparations; medical and chemical laboratories; scientific and industrial research relating to medicinal or veterinary practice; diagnostic and screening services relating to medicinal or veterinary research and development; informational services relating to medicinal or veterinary research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, February 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, February 14, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEgetis Therapeutics AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressSE

Trademark Events


Event DateEvent Description
Sunday, March 6, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, March 5, 2022DEATH OF INTERNATIONAL REGISTRATION
Sunday, December 19, 2021REFUSAL PROCESSED BY IB
Thursday, December 2, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 2, 2021REFUSAL PROCESSED BY MPU
Tuesday, November 2, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 1, 2021NON-FINAL ACTION WRITTEN
Thursday, October 28, 2021ASSIGNED TO EXAMINER
Friday, June 11, 2021APPLICATION FILING RECEIPT MAILED
Monday, June 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 5, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 3, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB